Correction: Hamilton et al. Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer. Int. J. Mol. Sci. 2017, 18, 2305

By sjmartinez • March 12, 2024

Hamilton N, Austin D, Márquez-Garbán D, Sanchez R, Chau B, Foos K, Wu Y, Vadgama J, Pietras R. Correction: Hamilton et al. Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer. Int. J. Mol. Sci. 2017, 18, 2305. Int J Mol Sci. 2024 Feb 23;25(5):2579. doi: 10.3390/ijms25052579. Erratum for: Int J Mol Sci. 2017 Nov 02;18(11): PMID: 38474325.

Tags: Endocrinology, General Internal Medicine, Hematology/Oncology, King Drew Med Ctr, Publications

Editorial: Mechanisms and novel therapeutic targets and approaches for mitochondrial dysfunction in neurological and cardiovascular diseases

Li Q, Zhang Q. Editorial: Mechanisms and novel therapeutic targets and approaches for mitochondrial dysfunction in neurological and cardiovascular diseases. Front Physiol. 2026 Apr 21;17:1840059.[...]

Plasma metabolomic profiles associated with cardiovascular disease in type 2 diabetes from the Trans-Omics for Precision Medicine (TOPMed) program

Zhang Y, Nguyen NQH, Hanson PA, Sevilla-Gonzalez M, Haessler J, Sarnowski C, Yao J, Yu B, Jamshidi A, Boerwinkle E, Brown MR, Chen ZZ, Ida[...]

Stabilizing and strengthening the U.S. physician-scientist faculty workforce in academic medicine: a proposed institutional framework

Williams CS, Allen M, Cooper Byas P, Hawley JB, Muglia LJ, Abel ED, Bastarache JA, Calfee CS, Carethers JM, Cornfield DN, Eickelberg O, Gallagher EJ,[...]